Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Phase 2
Completed
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Drug: 12.5mg sunitinib with Cisplatin and GemcitabineDrug: 25mg Sunitinib alternating with Cisplatin and GemcitabineDrug: 7.5mg/kg Bevacizumab alternating with Cisplatin and GemcitabineDrug: 2.5mg/kg Bevacizumab alternating with Cisplatin and Gemcitabine
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 80
- Registration Number
- NCT01309633
- Locations
- 🇸🇬
National University Hospital, Kent Ridge, Singapore
Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
Phase 2
- Conditions
- ErbB2-Positive Stage I-III Breast Cancer
- Interventions
- Drug: paclitaxel/carboplatin/lapatinib
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 34
- Registration Number
- NCT01309607
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Zinc Supplementation in Type 2 Diabetics
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Zinc gluconate
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 40
- Registration Number
- NCT01309620
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
- Conditions
- Breast Tumor
- First Posted Date
- 2010-11-24
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- National University Hospital, Singapore
- Registration Number
- NCT01247480
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot Study
- Conditions
- Breast Tumor
- Interventions
- Other: Breast Tumor Blocks
- First Posted Date
- 2010-11-24
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 10
- Registration Number
- NCT01247467
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Breast Cancer Registry - National University Health System, Singapore
- Conditions
- Breast Cancer
- First Posted Date
- 2010-11-24
- Last Posted Date
- 2014-01-14
- Lead Sponsor
- National University Hospital, Singapore
- Registration Number
- NCT01247441
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib.
- Conditions
- Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib
- Interventions
- Procedure: Tumor biopsies
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- National University Hospital, Singapore
- Registration Number
- NCT01227746
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
- Conditions
- Breast Cancer
- Interventions
- Other: Breast Tumor Blocks
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- National University Hospital, Singapore
- Registration Number
- NCT01227733
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
Phase 2
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 30
- Registration Number
- NCT01228045
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Phase 1
- Conditions
- Gastric Cancer
- Interventions
- Biological: OTSGC-A24
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 23
- Registration Number
- NCT01227772
- Locations
- 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
🇯🇵Wakayama Medical University Hospital, Wakayama, Japan
🇸🇬National University Hospital, Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath